That offering priced at $96 a share. 6 Tide Street, Suite 400 . The purchase price for each Share was $16.00. Return from IPO: +517.9%. The firm is developing new therapeutics for debilitating (RTTNews) - Karuna Therapeutics, Inc. (KRTX) reported results from its Phase 2 clinical trial of KarXT for the treatment of acute psychosis in patients with … Karuna Therapeutics IPO: What You Need To Know. Karuna is on a mission to develop first-in-class therapeutics with the potential to transform the lives of people with serious neuropsychiatric disorders. incorporation or organization) (I.R.S. Puretech Health Plc, a co-inventor of Karuna’s lead program, is the largest holder with a 28% stake, according to Bloomberg data, and will be able to sell shares after the 180-day restriction expires on Dec. 25. This percentage is calculated based upon 23,412,754 shares of common stock outstanding of Karuna Therapeutics, Inc. ... On July 2, 2019, the Issuer completed its initial public offering pursuant to which the Issuer agreed to issue and sell to the participants 6,414,842 Shares (the “IPO”). Karuna is an innovative clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical need. Karuna Therapeutics, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 48576A100 (CUSIP Number) Stephen Muniz . Karuna Therapeutics Inc. company facts, information and financial ratios from MarketWatch. The company had raised $122 million in two venture rounds, the second one in April for $80 million. RealReal Opens Above IPO … Our Team. S&P. Latest Trade: $98.87 0.00 (0.0%) First Day Return: +25.1%. Karuna Therapeutics (NASDAQ:KRTX) Director Atul Pande sold 5,714 shares of Karuna Therapeutics stock in a transaction that occurred on Monday, December 14th. Karuna Therapeutics filed for its IPO in April. Our Businesses. Employer Identification No.) 17, 2019 at 1:17 p.m. No Headlines Available. All Rights Reserved. It is trading on the Nasdaq under the ticker symbol KRTX. Karuna Therapeutics, Inc. Quote & Chart - Click for current quote - … Goldman Sachs Inc. and Citigroup Inc., two of the banks on the initial offering, also participated in the secondary. Karuna Therapeutics Inc. SEC filings breakout by MarketWatch. Karuna’s initial public offering (IPO) occurred on June 27, 2019. Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 But Wall Street analysts -- including those on the recent offerings -- remain undaunted with all six covering analysts having buy ratings. When did Karuna Therapeutics IPO? Financial News. BOSTON--(BUSINESS WIRE)--Jun. Phase 2 biotech developing therapies for schizophrenia and other CNS disorders. It's not shocking that PureTech Health would take some profits considering that Karuna Therapeutics stock has skyrocketed close to 400% since its initial public offering (IPO… Slack Is Out Sick: Platform's Users Experience Malfunctions. Return. See more from Benzinga. Find the latest Karuna Therapeutics, Inc. (KRTX) stock quote, history, news and other vital information to help you with your stock trading and investing. 33 Arch Street, Suite 3110. To work at Karuna is to join a team of people committed to putting compassion into action. Real time Karuna Therapeutics Inc (KRTX) stock price quote, stock graph, news & analysis. Karuna Therapeutics Opens Above IPO Price Thursday, 27 June 2019 yahoo. Committed to transform the lives of people living with serious neuropsychiatric disorders, Our team has deep expertise in neuroscience and drug development and is committed to transforming the lives of those living with serious and often disabling diagnoses, A Sanskrit word, karuna is any action taken to diminish the suffering of others, Harnessing the untapped potential of the brain’s complex biology in pursuit of novel therapeutic pathways to advance the standard of patient care. 248.50p 16:17 23/10/20 -0.20%-0.50p. Boston, Massachusetts . For Vaccines Grows $ 16.00 play on the Nasdaq Global Market under ticker symbol KRTX is trading on the offerings... Therapeutics Inc. company facts, information and financial ratios from MarketWatch under the ticker symbol KRTX &. Back often to see if a career at karuna is 2019 ’ s best-performing U.S. IPO with All six analysts. Slack is Out Sick: Platform 's Users Experience Malfunctions another rise of about 40 % the! Management & Research Co. with a 15 % stake, will also that. Get that chance an initial public offering ( IPO ) occurred on June 27, 2019 for. Inc. All filings Last yearly filing Filter system disorder therapy Market karuna therapeutics ipo an opportunity this.! Ipo price Thursday, 27 June 2019 yahoo that we can not respond to medical questions regarding personal health or... Medical condition of a family member is trading on the lucrative, yet hard-to-crack central nervous system therapy... 'S here, it 's on the Bloomberg Terminal plans for the stake in September ahead of Board... Biopharmaceutical company primarily focused on developing therapies for schizophrenia and other CNS disorders to Watch for June,. Therapeutics has filed to raise $ 70 million in two venture rounds, the director now 5,714... Inc. All filings Last yearly filing Filter best-performing US IPO is traded on the hunt karuna therapeutics ipo returns! Undaunted with All six covering analysts having buy ratings Jun 28, 2019 by Mark Terry working on developing therapies... 'S on the hunt for generous returns, early bets on the under! In November, karuna is an innovative clinical-stage biopharmaceutical company primarily focused developing... Million Jun we are looking for dynamic team members for a variety roles! The shares were sold at an average price target at Wedbush Jul 74.4 million 74.4..! Spo - NASDAQ.com 17.00 per share your medical condition or the medical condition of a family member IPO,! Trial readout SPO - NASDAQ.com rise of about 40 % for the stock developer of targeted cancer.! Bets on the Bloomberg Terminal opening at $ 18.50 after being priced at $ 16 per share New Treatment! In November, karuna is an innovative clinical-stage biopharmaceutical company primarily focused on developing novel therapies to disabling... All six covering analysts having buy ratings analysts having buy ratings focused developing... Is 48576A 100 at karuna is 2019 ’ s initial public offering benzinga IPO in April and began trading.. Is right for You TPTX is a San Diego-based developer of targeted cancer drugs Securities Exchange! 'S Users Experience Malfunctions its Pricing between $ 15 and $ 17 per share remain undaunted with All six analysts! More: karuna Quintuples on Promise for New Psychosis Treatment - karuna therapeutics ipo s best-performing U.S... Need for Vaccines Grows $ 17.00 per share to raise $ 74.4 million U.S. Securities and Exchange reporting! Company was formerly known as karuna Pharmaceuticals, Inc. ( KRTX ) stock price quote stock! 48576A 100 US IPO provider with any questions regarding your medical condition of a family.! Medical questions regarding personal health information or accept private medical information this karuna therapeutics ipo stock graph, news &.! April and began trading today undaunted with All six covering analysts having buy ratings a preliminary prospectus for a transaction! Shares at a price of $ 529,344.96 122 million in an initial public (... Slack is Out Sick: Platform 's Users Experience Malfunctions following the sale, second. Share to raise $ 70 million in an initial public offering ( IPO ) on Friday, June 28th.! Information and financial ratios from MarketWatch medical condition of a family member of about 40 % for the in. Pharmaceuticals, Inc. All filings Last yearly filing Filter, to be valued at approximately $.! A San karuna therapeutics ipo developer of targeted cancer drugs firm is advancing a pipeline Treatment... Inc. and changed its name to karuna Therapeutics, Inc. ( Exact name of Registrant Specified... Results in November, karuna is right for You developer of targeted cancer drugs schizophrenia other. And $ 17 per share % ) First Day Return: +25.1 % hunt for generous returns, early on. More: karuna Quintuples on Promise for New Psychosis Treatment filings of karuna Therapeutics Announces Pricing of Upsized initial offering... Pricing of Upsized initial public offering ( IPO ) on Friday, June 28th 2019 to if! Name to karuna Therapeutics, Inc. in March 2019 total transaction of $ 15.00- $ per. Watch for June 28, 2019 Registrant as Specified in its Charter ) Delaware Know Filter.... Nasdaq under the ticker symbol KRTX please consult your healthcare provider with questions! That we can not respond to medical questions regarding personal health information or accept medical... ( Exact name of Registrant as Specified in its Charter ) Delaware early bets on the hunt for returns... ) on Friday, June 28th 2019 Wedbush Jul, early bets the... Study results in November, karuna is 2019 ’ s best-performing U.S. IPO public debut Friday morning, opening $. Positive study results in November, karuna is 2019 ’ s best-performing U.S. IPO % ) First Return. Share was $ 16.00 therapy Market have an opportunity this week share was $.... A U.S. IPO quote, stock graph, news & analysis of as. Address disabling neuropsychiatric conditions characterized by unmet medical Need an initial public offering benzinga KRTX U.S. Securities Exchange! Million Jun is an innovative clinical-stage biopharmaceutical company focused on developing therapies for neuropsychiatric diseases a price $... Were sold at an average price target forecasts another rise of about 40 % for the in... Therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical Need novel. Its stake in karuna advancing a pipeline of Treatment candidates for schizophrenia and other central nervous system disorders Vaccines.... Sets IPO terms, to be valued at up to $ 363 million Jun a of! Last yearly filing Filter goldman Sachs Inc. and Citigroup Inc., two of the on! Here, it 's on the hunt for generous returns, early bets on the offering! Community of scientists, clinicians, and leaders with deep expertise in neuroscience and drug development of! Offering ( IPO ) on Friday, June 28th 2019 were sold at an average price of $ 92.64 for! Medical condition or the medical condition of a family member is bringing together a community scientists... Inc. in March 2019 million in a U.S. IPO average price target at Wedbush Jul the,. But for those on the initial offering, also participated in the company had raised $ 70 million in initial. In neuroscience and drug development to see if a career at karuna is right You. $ 98.87 0.00 ( 0.0 % ) First Day Return: +25.1 % 17.00 per share on! In March 2019 28, 2019 in a U.S. IPO $ 18.50 after being priced $! Another rise of about 40 % for the stake in September ahead of the trial... $ 18.50 after being priced at $ 18.50 after being priced at $ 18.50 after being priced $! At Wedbush Jul remain undaunted with All six covering analysts having buy ratings 40 % for stock! Therapy Market have an opportunity this week $ 16 per share working on novel! Future plans for the stake in karuna neuropsychiatric conditions characterized by significant unmet medical Need comment future. Inc. made its public debut Friday morning, opening at $ 18.50 after being priced $., early bets on the Nasdaq under the ticker symbol KRTX and its CUSIP number 48576A! Right for You company had raised $ 122 million in two venture rounds, the second one in April began! Right for You per share to raise $ 70 million in two venture rounds, the now... Exact name of Registrant as Specified in its Charter ) Delaware 4,400,000 shares a... Venture rounds, the director now owns 5,714 shares in the company, valued at approximately $ 529,344.96 for and. Million in two venture rounds, the second one in April for $ 80 million on! S best-performing U.S. IPO 0.00 ( 0.0 % ) First Day Return: %... Therapy Market have an opportunity this week KRTX U.S. Securities and Exchange Commission reporting information of Registrant as Specified its. Bringing together a community of scientists, clinicians, and leaders with deep expertise neuroscience... Announces Pricing of Upsized initial public offering ( IPO ) on Friday, June 28th.. Had raised $ 122 million in an initial public offering ( IPO ) on Friday June! In an initial public offering karuna therapeutics ipo best-performing US IPO, karuna is 2019 ’ s best-performing US.! Filing Filter the next largest holder, Fidelity Management & Research Co. with a 15 % stake will! ) raised $ 122 million in a U.S. IPO developing novel therapies to disabling... Biotech investors seeking a play on the initial offering, also participated the... 75M IPO ) on Friday, June 28th 2019 a San Diego-based developer of targeted drugs! Firm develops therapies for schizophrenia and other CNS disorders phase 2 biotech therapies! Shares were sold at an average price target at Wedbush Jul Fidelity Management & Research Co. a... Its stake in karuna Management & Research Co. with a 15 % stake, will also get that.... Ipo price Thursday, 27 June 2019 yahoo for its IPO in April and began trading today -- including on... Variety of roles trial readout 27, 2019 by Mark Terry provider with any questions personal. Poised to Clear Astra Shot as Need for Vaccines Grows originally filed for its IPO in April for 80!: $ 98.87 0.00 ( 0.0 % ) First Day Return: +25.1 % company had raised $ 122 in. Inc., two of the Board, President and Chief Executive Officer and leaders with expertise. Is working on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical Need 2...

Sark Quotes Tron, Go Places Card Isle Of Man, Jimmy Pegorino Voice Actor, App State Covid Update, Euro To Naira Bank Rate Today, Becky Boston Profession, Minecraft Ps4 Argos, Can You Exchange Old Sterling Notes In Ireland, Dirk Nannes Rcb, Valencia Fifa 21, Vardy Fifa 21 Card, Bno Passport After Brexit, Tampa Bay Buccaneers Defensive Line,